Revenue from operations is likely to jump 10% year-on-year (YoY), according to the average estimate of four brokerages. Meanwhile, net profit for the quarter is projected to rise by up to 25% YoY. The pharma major will report its September quarter results on Monday, October 28.
| Subscribe To Our Free Newsletter |
